Trial record 1 of 1 for:    NCT01839656
Previous Study | Return to List | Next Study

A Study to Assess the Safety and Pharmacokinetics of ISIS SMNRx in Infants With Spinal Muscular Atrophy

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by Isis Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
Isis Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01839656
First received: April 22, 2013
Last updated: October 22, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)